Autor(es)

Sasso, B. M. ; Vallarelli, A. F. A. ; Rosa, P. S. ; Belone, A. F. F. ; Velho, P. E. N. F. ; Cintra, Maria Leticia

• Tipo de documento: Artigo Científico
• Fonte: Microbial Pathogenesis; v. 190, p. 9-pg., 2024-03-21.

Resumo

Jorge Lobo's disease (JLD) and lepromatous leprosy (LL) share several clinical, histological and immunological features, especially a deficiency in the cellular immune response. Macrophages participate in innate and adaptive inflammatory immune responses, as well as in tissue regeneration and repair. Macrophage function deficiency results in maintenance of diseases. M1 macrophages produce pro-inflammatory mediators and M2 produce antiinflammatory cytokines. To better understand JLD and LL pathogenesis, we studied the immunophenotype profile of macrophage subtypes in 52 JLD skin lesions, in comparison with 16 LL samples, using a panmacrophage (CD68) antibody and selective immunohistochemical markers for M1 (iNOS) and M2 (CD163, CD204) responses, HAM56 (resident/fixed macrophage) and MAC 387 (recently infiltrating macrophage) antibodies. We found no differences between the groups regarding the density of the CD163, CD204, MAC387+ immunostained cells, including iNOS, considered a M1 marker. But HAM56+ cell density was higher in LL samples. By comparing the M2 and M1 immunomarkers in each disease separately, some other differences were found. Our results reinforce a higher M2 response in JLD and LL patients, depicting predominant production of antiinflammatory cytokines, but also some distinction in degree of macrophage activation. Significant amounts of iNOS + macrophages take part in the immune milieu of both LL and JLD samples, displaying impaired microbicidal activity, like alternatively activated M2 cells. (AU)

• Processo FAPESP: 17/17149-8 - Perfil imunofenotípico do infiltrado macrofágico na doença de jorge lobo e hanseníase virchowiana - análise comparativa
• Beneficiário: Maria Letícia Cintra
• Modalidade de apoio: Auxílio à Pesquisa - Regular